NanoViricides Reaches an Agreement on Terms of License for Shingles Virus Drug Development - PRNewswire

NanoViricides Reaches an Agreement on Terms of License for Shingles Virus Drug Development  PRNewswire

SHELTON, Conn., Feb. 26, 2019 /PRNewswire/ -- NanoViricides, Inc. (NYSE MKT: NNVC) (the "Company") a global leader in the development of highly effective ...